Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in germany

Medical Microbiology and Immunology

Volumn 191, Issue 2, 2002, Pages 89-96

  Wutzler, Peter ^a   Neiss, Albrecht ^b   Banz, Kurt ^c   Goertz, Anita ^d   Bisanz, Helmtrud ^d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Outcomes International   (Switzerland)

^d GLAXOSMITHKLINE   (Germany)

Author keywords

Cost benefit analysis; Elimination; Epidemiology; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; VIRUS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHICKENPOX; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; GERMANY; HEALTH STATUS; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFANT; INFECTION; MAJOR CLINICAL STUDY; MEASLES; MEDICAL DECISION MAKING; NONHUMAN; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; SEROPREVALENCE; TIME; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; CHICKENPOX; CHICKENPOX VACCINE; CHILD; FEMALE; GERMANY; HEALTH CARE COSTS; HERPESVIRUS 3, HUMAN; HUMANS; INFANT, NEWBORN; MALE; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; VACCINATION;

EID: 0036398843     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-002-0123-4     Document Type: Article

References (32)

1. American Academy of Pediatrics. Committee on Infectious Diseases (2000) Varicella vaccine update. Pediatrics 105:136-1413
2. Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S (1994) Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 94:524-526
3. Banz K, Neiss A, Goertz A, Klose T, Wutzler P (2002) Routine varicella vaccination of children is effective and cost-beneficial in Germany. Eur J Health Econom 3 [Suppl 1]: S64
4. Beutels P, Clara R, Tormans G, Van Doorslaer E, Van Damme P (1996) Costs and benefits of routine varicella vaccination in German children. J Infect Dis 174 [Suppl 3]:S335-341
5. Bolker BM, Grenfell BT (1993) Chaos and biological complexity in measles dynamics. Proc R Soc Lond B Biol Sci 251:75-81
6. Centers for Disease Control and Prevention (1996) Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 45(RR-11):1-36
7. Choo PW, Donahue JG, Manson JE, Platt R (1995) The epidemiology of varicella and its complications. J Infect Dis 172:706-712
8. Encyclopaedia of Clinical Practice (EPIC) Volume 1.1 (1996) The G. P. Database Research Company, London
9. Edmunds WJ, Pebody RG, Aggerback H et al (2000) The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 125:113-125
10. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343:1548-1551
11. Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L (1994) Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 140:81-104
12. Halloran ME (1996) Epidemiologic effects of varicella vaccination. Clin North Am 10:631-655
13. Hardy I, Gershon AA, Steinberg SP, LaRussa P(1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 325:1545-1550
14. Izurieta HS, Strebel PM, Blake PA (1997) Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 278:1495-1449
15. Krause PR, Klinman DM (2000) Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med 6:1299-1300
16. Lieu TA, Cochi SL, Black SB, Halloran E, Shinefield HR, Holmes SJ, Wharton M, Washington E (1994) Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 271:375-381
17. Meyer PA, Seward JF, Jumaan AO, Wharton M (2000) Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 182:383-390
18. Miller E, Vurdien J, Farrington P(1993) Shift in age in chickenpox. Lancet 341:308-309
19. Perscription index for Pharmaceuticals 2000; Database provided by: IMS Health Germany GmbH and Co OHG; http:// www.imshealth.de
20. Robert Koch-Institut (2001) Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epide-miologisches Bulletin 28:204-218
21. Sauerbrei A, Sonntag S, Wutzler P (1990) Durchseuchung von Schwangeren mit dem Varicella-Zoster-Virus. Zentralbl Gynäkol 112:223-226
22. Schneweis KE, Krentler C, Wolff MH (1985). Durchseuchung mit dem Varicella-Zoster-Virus und serologische Feststellung der Erstinfektionsimmunität. Dtsch Med Wochenschr 110:453-457
23. Sloan DS, Burlison A (1992) Shift in age in chickenpox. Lancet 340:974
24. Statistisches Bundesamt Wiesbaden (2000) Statistisches Jahrbuch für die Bundesrepublik Deutschland 2000. Metzler-Poeschel, Stuttgart
25. Thefeld W, Stolzenberg H, Bellach BM (1999) The Federal Health Survey: response, composition of participants and non-responder analysis. Gesundheitswesen 61:S57-61
26. Wagenpfeil S, Neiss A, Bisanz H, Wutzler P, Vollmar J, Goertz A (2002) Epidemiology of varicella infection to assess burden of disease in Germany. Clin Microbiol Infect 8 [Suppl 1]:43
27. Watson BM, Piercy SA, Plotkin SA, Starr SE (1993) Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 91:17-22
28. Windorfer A, Strutz R, Misera B (1994) Child disease and vaccination. Der Kinderarzt 25:275-280
29. Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121-124
30. Van Damme P, Beutels P (1996) Economic evaluation of vaccination. Pharmaco Economics 9 [Suppl 3]:8-15
31. Varis T, Vesikari T (1996) Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 174 [Suppl 3]:S330-334
32. Ziebold C, Kries R von, Lang R, Weigl J, Schmitt HJ (2001) Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 108:79-84